TCT Hallway Buzz: The BRIGHT Trial

WASHINGTON (MedPage Today) -- The BRIGHT trial favored bivalirudin (Angiomax) over heparin in PCI, but was the heparin dose responsible? In this exclusive video, Rod H. Stables, MA, DM, discusses some caveats.
Source: MedPage Today Meeting Coverage - Category: Journals (General) Source Type: news